CSRC approves Sanyi Intelligent's listing on the ChiNext board.
On January 23, the China Securities Regulatory Commission issued a reply regarding the approval of the initial public offering of shares for Nanchang Sanrui Intelligent Technology Co., Ltd.
On January 23, the China Securities Regulatory Commission released the "Approval for the Initial Public Offering of Shares by Nanchang Sanrui Intelligent Technology Co., Ltd." It is reported that Sanrui Intelligent plans to list on the ChiNext board of the Shenzhen Stock Exchange, with Guotai Haitong as the sponsoring institution, intending to raise 768.88 million yuan.
According to the prospectus, Sanrui Intelligent is a manufacturer of drone and Siasun Robot & Automation power systems, mainly engaged in the research, development, production, and sales of drone electric power systems and Siasun Robot & Automation power systems, actively laying out products for electric vertical take-off and landing aircraft (eVTOL) power systems.
In terms of drone electric power systems, the company's products include electric motors, electronic speed controllers, propellers, and integrated power systems for all types of electric power systems, with end applications in vertical fields such as agricultural plant protection, industrial inspections, surveying and mapping, express logistics, emergency rescue, and security monitoring, adaptable to various types of drones including multi-rotor, fixed-wing, and hybrid-wing.
In terms of Siasun Robot & Automation power systems, the company established its independent brand CubeMars in 2018, focusing on the Siasun Robot & Automation articulation field, and has achieved independent research and production of core components such as motors, drive boards, and planetary gearboxes in the Siasun Robot & Automation power module. The company's products can be applied in human-like Siasun Robot & Automation, exoskeletons and wearable devices, and quadruped Siasun Robot & Automation in many emerging fields.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


